From randomization, reductions in FPG, HbA 1c , and in the prevalence of prediabetes and metabolic syndrome, were observed during the trial
And a dramatic reduction in the risk of a secondary cardiovascular event (heart attack and strokes) in patients that have already suffered an event
Likewise, in the SURPASS-3 trial, all three doses of TZP caused a significant decrease in mean SBP from baseline (from 4.9 to 6.6 mmHg)
This effect can lead to a reduced caloric intake, which is particularly beneficial for individuals who find it challenging to manage their weight through diet and exercise alone
Your prescriber can help decide whether symptoms are mild dryness, a side effect, or a separate condition
If brand Zepbound or Wegovy is covered at a copay you can sustain, use brand